Tissue transglutaminase: An emerging target for therapy and imaging

被引:31
作者
Pietsch, Markus [1 ]
Wodtke, Robert [2 ,3 ]
Pietzsch, Jens [2 ,3 ]
Loeser, Reik [2 ,3 ]
机构
[1] Univ Hosp Cologne, Inst Pharmacol, D-50931 Cologne, Germany
[2] Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharmaceut Canc Res, D-01328 Dresden, Germany
[3] Tech Univ Dresden, Dept Chem & Food Chem, D-01062 Dresden, Germany
关键词
Tissue transglutaminase (TGase 2); Cancer; Biomaterial-tissue interface; Activity assays; Inhibitors; Imaging probes; COAGULATION-FACTOR-XIII; PIG LIVER TRANSGLUTAMINASE; NF-KAPPA-B; SENSITIVE FLUOROMETRIC ASSAY; INDEPENDENT CELL-ADHESION; GLUTEN PEPTIDE ANALOGS; PROTEIN CROSS-LINKING; HEPARIN-BINDING-SITE; ACTIVE-SITE; IRREVERSIBLE INHIBITORS;
D O I
10.1016/j.bmcl.2013.09.060
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Tissue transglutaminase (transglutaminase 2) is a multifunctional enzyme with many interesting properties resulting in versatile roles in both physiology and pathophysiology. Herein, the particular involvement of the enzyme in human diseases will be outlined with special emphasis on its role in cancer and in tissue interactions with biomaterials. Despite recent progress in unraveling the different cellular functions of transglutaminase 2, several questions remain. Transglutaminase 2 features in both confirmed and some still ambiguous roles within pathological conditions, raising interest in developing inhibitors and imaging probes which target this enzyme. One important prerequisite for identifying and characterizing such molecular tools are reliable assay methods to measure the enzymatic activity. This digest Letter will provide clarification about the various assay methods described to date, accompanied by a discussion of recent progress in the development of inhibitors and imaging probes targeting transglutaminase 2. (C) 2013 The Authors. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:6528 / 6543
页数:16
相关论文
共 223 条
  • [1] Ataxia-Telangiectasia, Mutated (ATM)/Nuclear Factor κ Light Chain Enhancer of Activated B Cells (NFκB) Signaling Controls Basal and DNA Damage-induced Transglutaminase 2 Expression
    Ai, Lingbao
    Skehan, Ryan R.
    Saydi, John
    Lin, Tong
    Brown, Kevin D.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (22) : 18330 - 18341
  • [2] Microvesicles Messengers and mediators of tumor progression
    Al-Nedawi, Khalid
    Meehan, Brian
    Rak, Janusz
    [J]. CELL CYCLE, 2009, 8 (13) : 2014 - 2018
  • [3] Development of an isoenzyme-specific colorimetric assay for tissue transglutaminase 2 cross-linking activity
    Alea, Mileidys Perez
    Kitamura, Miyako
    Martin, Guillaume
    Thomas, Vincent
    Hitomi, Kiyotaka
    El Alaoui, Said
    [J]. ANALYTICAL BIOCHEMISTRY, 2009, 389 (02) : 150 - 156
  • [4] Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells
    Antonyak, Marc A.
    Li, Bo
    Boroughs, Lindsey K.
    Johnson, Jared L.
    Druso, Joseph E.
    Bryant, Kirsten L.
    Holowka, David A.
    Cerione, Richard A.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (12) : 4852 - 4857
  • [5] Recent advances in the development of tissue transglutaminase (TG2) inhibitors
    Badarau, E.
    Collighan, R. J.
    Griffin, M.
    [J]. AMINO ACIDS, 2013, 44 (01) : 119 - 127
  • [6] Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors
    Badarau, Eduard
    Mongeot, Alexandre
    Collighan, Russell
    Rathbone, Dan
    Griffin, Martin
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 66 : 526 - 530
  • [7] Baek KJ, 1996, BIOCHEM J, V315, P739
  • [8] Extracellular TG2: emerging functions and regulation
    Belkin, Alexey M.
    [J]. FEBS JOURNAL, 2011, 278 (24) : 4704 - 4716
  • [9] DIFFERENCES IN THE POSTTRANSLATIONAL MODIFICATION OF PROTEINS BY POLYAMINES BETWEEN WEAKLY AND HIGHLY METASTATIC B16 MELANOMA-CELLS
    BENINATI, S
    ABBRUZZESE, A
    CARDINALI, M
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1993, 53 (05) : 792 - 797
  • [10] Transglutaminase 2 and NF-κB: an odd couple that shapes breast cancer phenotype
    Brown, Kevin D.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (02) : 329 - 336